CERS5 and steatosis: Although the reason for this is not clear, it is tempting to speculate that this C16:0 ceramide in females is produced by CerS5 in distinct subcellular location that does not contribute to steatosis and insulin resistance [7], as it is known that location of ceramide accumulation in different organelles dictates its actions [9].